Literature DB >> 311204

Anti-dsDNA and complement profiles as prognostic guides in systemic lupus erythematosus.

A J Swaak, L A Aarden, L W Statius van Eps, T E Feltkamp.   

Abstract

Antibodies to dsDNA, tested with circular DNA in the Farr assay, are specific for systemic lupus erythematosus. A longitudinal study showed a clear relation between the clinical state, the anti-dsDNA titer (expressed in units), and the C1q and C3 levels: when anti-dsDNA levels remained high, no exacerbations were observed. A sharp drop in anti-dsDNA, usually preceded by a rise, was related to a serious exacerbation. Only during the exacerbation when both C1q and C3 were very low was renal involvement seen.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 311204     DOI: 10.1002/art.1780220304

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  82 in total

Review 1.  The use of laboratory tests in the diagnosis of SLE.

Authors:  W Egner
Journal:  J Clin Pathol       Date:  2000-06       Impact factor: 3.411

2.  The role of somatic mutation in determining the affinity of anti-DNA antibodies.

Authors:  M Behrendt; L J Partridge; B Griffiths; M Goodfield; M Snaith; N J Lindsey
Journal:  Clin Exp Immunol       Date:  2003-01       Impact factor: 4.330

3.  Disease activity in systemic lupus erythematosus related to a range of antibodies binding DNA and synthetic polynucleotides.

Authors:  D A Isenberg; C Dudeney; W Williams; A Todd-Pokropek; B D Stollar
Journal:  Ann Rheum Dis       Date:  1988-09       Impact factor: 19.103

4.  Anti-Klebsiella K30 phospholipid antibodies in systemic lupus erythematosus: antigen cross-reactions and idiotypic sharing with antibodies to DNA and Klebsiella K30 polysaccharide.

Authors:  G D Harkiss; F M Hendrie; D Thompson
Journal:  J Clin Immunol       Date:  1988-07       Impact factor: 8.317

5.  Complement (C3) metabolism in rheumatoid arthritis in relation to the disease course.

Authors:  A J Swaak; H Han; A van Rooyen; M Pillay; C E Hack
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

6.  Assessment of class-specific antibodies against denatured DNA in patients with systemic lupus erythematosus.

Authors:  M Gripenberg; M Leirisalo; E Johansson; G Gripenberg
Journal:  J Clin Immunol       Date:  1985-09       Impact factor: 8.317

7.  Anti-DNA antibodies of IgA class in patients with systemic lupus erythematosus.

Authors:  M Gripenberg; T Helve
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

8.  Chronic serum sickness in the rat: influence of antigen dose, route of antigen administration and strain of rat on the development of disease.

Authors:  B Noble; M Milgrom; J B Van Liew; J R Brentjens
Journal:  Clin Exp Immunol       Date:  1981-12       Impact factor: 4.330

9.  Investigation of the prevalence and clinical associations of antibodies to human fibronectin in systemic lupus erythematosus.

Authors:  M S Atta; K L Lim; D A Ala'deen; R J Powell; I Todd
Journal:  Ann Rheum Dis       Date:  1995-02       Impact factor: 19.103

10.  Assessment of lupus: where are we now?

Authors:  E Hay; C Gordon; P Emery
Journal:  Ann Rheum Dis       Date:  1993-03       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.